Wells Fargo & Company Mei Pharma, Inc. Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.21 - $0.35 $5,562 - $9,270	-26,488 Reduced 10.1%	235,773 $54,000
Q4 2022 Feb 13, 2023	SELL	$0.22 - $8.4 $75,386 - $2.88 Million	-342,666 Reduced 56.65%	262,261 $62,000
Q3 2022 Nov 14, 2022	SELL	$0.41 - $8.8 $7,093 - $152,240	-17,300 Reduced 2.78%	604,927 $234,000
Q2 2022 Aug 12, 2022	SELL	$0.42 - $0.65 $71,409 - $110,514	-170,023 Reduced 21.46%	622,227 $376,000
Q1 2022 May 16, 2022	SELL	$0.54 - $2.74 $12,300 - $62,414	-22,779 Reduced 2.79%	792,250 $477,000
Q4 2021 Feb 14, 2022	BUY	$2.33 - $3.37 $7,034 - $10,174	3,019 Added 0.37%	815,029 $2.18 Million
Q3 2021 Nov 15, 2021	SELL	$2.52 - $2.99 $93,287 - $110,686	-37,019 Reduced 4.36%	812,010 $2.24 Million
Q2 2021 Aug 16, 2021	BUY	$2.6 - $3.65 $276,361 - $387,969	106,293 Added 14.31%	849,029 $2.42 Million
Q1 2021 May 13, 2021	SELL	$2.73 - $4.5 $161,564 - $266,314	-59,181 Reduced 7.38%	742,736 $2.55 Million
Q4 2020 Feb 09, 2021	BUY	$2.6 - $3.32 $125,187 - $159,854	48,149 Added 6.39%	801,917 $2.12 Million
Q3 2020 Nov 05, 2020	BUY	$2.46 - $4.27 $216,666 - $376,084	88,076 Added 13.23%	753,768 $2.35 Million
Q2 2020 Aug 13, 2020	BUY	$1.45 - $4.3 $460,319 - $1.37 Million	317,462 Added 91.16%	665,692 $2.75 Million
Q1 2020 May 14, 2020	BUY	$0.75 - $2.55 $261,172 - $887,986	348,230 New	348,230 $561,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $385M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.